从慢性肾脏病向肾衰竭过渡:患者视角的混合方法研究
无论准备程度如何,患者均经历动荡、恐惧与未做好准备,多数在医院开始透析且几乎全部接受中心血液透析。研究提示需从健康系统层面改善这一关键过渡期的患者体验。
要点
- 无论既往肾脏科照护和透析通路准备程度如何,患者从CKD向肾衰竭过渡均感动荡与恐惧。
- 多数患者(93.6%)在医院开始透析,几乎所有患者(97.9%)接受中心血液透析。
- 患者因未意识到病情紧迫性而对肾衰竭诊断缺乏准备,诊断告知环境混乱但有效沟通有帮助。
核心结论
- 无论既往准备程度如何,参与者在从CKD向肾衰竭过渡期间均经历忧虑和恐惧。
- 成功解决影响这一关键照护过渡的可改变健康系统层面因素并直接关注患者体验,是改善照护和结局所必需的。
研究设计与样本
- 采用调查和访谈的收敛平行混合方法研究。
- 共纳入47名参与者,按既往肾脏科照护和透析通路放置情况分为三组:有一定既往照护且放置通路(n=23,48.9%)、极少肾脏科照护(有既往照护但未放置透析通路,n=13,27.7%)、无既往肾脏科照护或通路放置(n=11,23.4%)。
- 定性分析采用应用主题分析,定量数据进行全面描述。
主要发现
- 肾衰竭过渡对所有参与者(N=47)均是动荡的,无论准备程度如何。
- 透析开始沿紧迫性谱发生,多数(n=44;93.6%)在医院开始透析,几乎所有(n=46;97.9%)接受中心血液透析。
- 参与者对肾衰竭诊断缺乏准备,因为未意识到病情的紧迫性。
- 肾衰竭诊断沟通环境混乱,但有效的提供者沟通有帮助。
- 首次透析治疗以强烈的忧虑和恐惧为标志,参与者优先努力理解突然的新现实。
临床怎么用
- 临床应关注CKD向肾衰竭过渡期患者的情感和信息需求,即使已提供既往肾脏科照护和通路准备。
- 改善诊断告知环境和提供者沟通可能有助于减轻患者的未准备感和恐惧。
- 需要健康系统层面以患者为中心的项目,为患者提供应对重大生活变化所需的知识、资源和支持。
局限性
- 地理代表性有限。
- 排除了非英语参与者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The transition from chronic kidney disease (CKD) to kidney failure (KF) is life-changing. We explored the KF transition and dialysis start experiences of patients with varying degrees of prior nephrology care and preparation. STUDY DESIGN: Convergent parallel mixed-methods study using surveys and interviews. SETTING & PARTICIPANTS: Data were collected from December 2018 to January 2020 among adults in metropolitan Philadelphia who had recently transitioned from CKD to KF and started dialysis. ANALYTICAL APPROACH: Participants were categorized as having had (1) some prior nephrology care and placement of an arteriovenous or peritoneal dialysis access, (2) minimal nephrology care (prior nephrology care, but no placement of a dialysis access), or (3) no prior nephrology care or placement of an access. Applied thematic analysis guided the qualitative analysis, and quantitative data were fully described. RESULTS: KF transition was tumultuous for all participants (N = 47) regardless of preparation (some prior care, n = 23 [48.9%]; minimal prior care, n = 13 [27.7%]; no prior care, n = 11 [23.4%]). Dialysis start occurred along a spectrum of urgency, with most (n = 44; 93.6%) initiating dialysis in a hospital, and nearly all (n = 46; 97.9%) were treated with in-center hemodialysis. Four additional themes emerged: (1) participants were unprepared to receive the KF diagnosis because they were unaware of the urgency of their medical situation; (2) the KF diagnosis communication environment was chaotic, but effective provider communication helped; (3) the first dialysis treatment was marked by intense apprehension and fear; and (4) participants prioritized making sense of their sudden new reality. LIMITATIONS: Limited geographic representation and the exclusion of non-English-speaking participants. CONCLUSIONS: Irrespective of prior preparation, participants experienced apprehension and fear during the transition from CKD to KF. Successfully addressing modifiable health system-level factors that affect this critical care transition and directly address the patient experience is needed to improve care and outcomes. PLAIN-LANGUAGE SUMMARY: The progression from chronic kidney disease to kidney failure and dialysis is a challenging time for patients. We sought to understand the experiences of patients-those who had received prior kidney disease care and those who had not-during this transition to kidney failure and dialysis treatment. We interviewed and surveyed 47 patients in metropolitan Philadelphia within 5 months of their dialysis initiation to understand and compare their experiences. Nearly all participants described this transition as traumatic and chaotic, even those who had received prior kidney disease care. This study underscores the need for patient-centered, health system-level programs that equip patients with the knowledge, resources, and support necessary to cope with this major life change and ultimately improve patient outcomes.
引用
- Urbanski M, Siminoff LA, Waterman A, et al. Transitioning From CKD to Kidney Failure: A Mixed-Methods Study of Patient Perspectives. Am J Kidney Dis. 2026. PMID: 42025784. doi:10.1053/j.ajkd.2026.02.644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。